Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,708 shares at $979.25 ($1.7M) on 2024-02-26, disclosed to the SEC on 2024-02-26.
Open-market sale of $1.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $979.25 | 854 | $836K | 50.0% |
| 2 | $979.25 | 854 | $836K | 50.0% |
| Total | $979.25 avg | 1,708 | $1.7M | 100% |
| Filing → |
| REGN | SELL | 2024-08-19 | $885K | — | Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |